Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Missale

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 27, 2025
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world studyEdoardo G Giannini, Andrea Pasta, Laura Bucci, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Hepatology International|March 25, 2025
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinomaAlba Rocco, Costantino Sgamato, Filippo Pelizzaro, et al.
Gut|December 22, 2021
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA databaseAlessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Cell Reports. Medicine|June 14, 2023
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trialStefania Capone, Francesco M Fusco, Stefano Milleri, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Oncotarget|February 3, 2017
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitroRomina Salpini, Matteo Surdo, Nadia Warner, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 27, 2025
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world studyEdoardo G Giannini, Andrea Pasta, Laura Bucci, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Hepatology International|March 25, 2025
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinomaAlba Rocco, Costantino Sgamato, Filippo Pelizzaro, et al.
Gut|December 22, 2021
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA databaseAlessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Cell Reports. Medicine|June 14, 2023
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trialStefania Capone, Francesco M Fusco, Stefano Milleri, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Oncotarget|February 3, 2017
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitroRomina Salpini, Matteo Surdo, Nadia Warner, et al.
Pageof 12